CHICAGO, May 6, 2024 /PRNewswire/ -- Injectable Drug
Delivery Market in terms of revenue was estimated to be
worth $754.5 billion in 2024 and is
poised to reach $1139.4 billion by
2029, growing at a CAGR of 8.6% from 2024 to 2029 according to a
new report by MarketsandMarkets™.
The growth in the Injectable drug delivery market is mainly due
to an increase in technological advancements, an Increase in
chronic diseases, and an increase in government funding. The ageing
global population is pushing up demand for healthcare services and
drugs. Older persons frequently have complicated healthcare demands
and may require injectable medications to address chronic
illnesses, which contributes to the expansion of the injectable
drug delivery industry.
Emerging economies are seeing rapid urbanization, improved
healthcare infrastructure, and more healthcare spending, resulting
in greater access to injectable drugs. As a result, pharmaceutical
companies are focusing on extending their presence in these markets
to drive market growth.
Download an Illustrative overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150
Browse in-depth TOC on "Injectable Drug Delivery
Market"
350 - Tables
50 - Figures
450 -
Pages
Injectable Drug Delivery Market Scope:
Report
Coverage
|
Details
|
Market Revenue in
2024
|
$754.5
billion
|
Estimated Value by
2029
|
$1139.4
billion
|
Growth Rate
|
Poised to grow at a
CAGR of 8.6%
|
Market Size Available
for
|
2021–2029
|
Forecast
Period
|
2024–2029
|
Forecast
Units
|
Value (USD
Billion)
|
Report
Coverage
|
Revenue Forecast,
Competitive Landscape, Growth Factors, and Trends
|
Segments
Covered
|
Type, By Formulation
packaging, Therapeutic application, Usage Pattern, By site of
administration, distribution channel and facility of Use
|
Geographies
Covered
|
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of LATAM
- Middle East and Africa
- GCC Countries
- Rest of MEA
|
Report
Highlights
|
Updated financial
information / product portfolio of players
|
Key Market
Opportunities
|
Increase in demand for
biosimilars and generic medicine
|
Key Market
Drivers
|
Increased Prevalence of
Chronic Diseases
|
"By Therapeutic application, Infectious diseases holds the
largest share in 2023."
Injectable vaccinations prevent infectious diseases by
activating the immune system to create antibodies against certain
organisms. Vaccines are delivered intramuscularly or
subcutaneously to produce immunity to diseases such as influenza,
measles, polio, hepatitis, and COVID-19, among others. Injectable
drugs are widely used to treat chronic infectious disorders like
tuberculosis (TB) and HIV/AIDS. To efficiently target the TB germs
and prevent medication resistance, TB treatment frequently combines
oral antibiotics with injectable treatments such as rifampin,
isoniazid, and streptomycin. Similarly, injectable antiretroviral
medications can be used in HIV/AIDS therapy regimens to reduce
viral replication and prevent disease progression.
"By Usage Pattern Curative Care holds the largest share in
2023."
Based on usage patterns, the Injectable drug
delivery market is segmented into curative care, Immunization,
and Other usage patterns. Curative care holds the largest share
during the forecast period. Injectable drugs are frequently
utilised in curative care settings, such as hospitals and emergency
rooms, to treat acute medical illnesses that require prompt
attention. For example, injectable antibiotics, antivirals, and
analgesics may be used to treat infections, pain, and other acute
symptoms, allowing for faster recovery and resolution of the
illness. Injectable medication delivery allows for precise
administration of targeted medicines based on unique patient
characteristics, genetic profiles, and illness biomarkers. Targeted
therapies, such as monoclonal antibodies, immunotherapies, and gene
therapies, are injected to specifically target cancer cells, alter
immune responses, or correct genetic abnormalities, resulting in
cures or disease-modifying effects.
"Hospitals are the fastest-growing end users of the
Injectable drug delivery market in 2023."
Based on end users, the Injectable drug delivery market is
segmented into Hospitals and Retail Pharmacy centres. Hospitals
serve a wide range of medical disciplines, including surgery,
cancer, cardiology, neurology, infectious diseases, and others, all
of which may necessitate injectable drugs for diagnosis, treatment,
or prevention. Injectable medications are utilised in a variety of
medical fields to provide targeted therapies, perform diagnostic
tests, and offer supportive care to patients. Hospitals perform a
variety of medical procedures and interventions, including
surgeries, diagnostic imaging, interventional radiology, and
therapeutic interventions, which may necessitate the use of
injectable drugs before, during, or following the treatment.
Injectable medications are used extensively in anesthesia,
sedation, pain management, contrast enhancement, and other
procedures, which contributes to the overall demand for injectable
drug delivery in hospital settings.
"North America dominates the
global Injectable drug delivery market in 2023."
The Injectable drug delivery market is segmented into five major
regional segments, namely, North
America, Europe,
Asia Pacific, Latin America and Middle East and Africa. In 2023 North America accounted for
the largest share during the forecast period due to the following
reasons- North America has one of
the world's highest healthcare costs, thanks to innovative medical
technologies, expensive prescription drug prices, and a
comprehensive healthcare insurance system. The readiness to invest
in novel healthcare solutions, such as injectable drug delivery
systems, helps to drive market growth and adoption in the region.
North America is home to
world-class clinical research institutes, university medical
centres, and pharmaceutical research hubs that perform clinical
trials, translational research, and technology development for
injectable drug delivery. Collaborations among academia, industry,
and government organizations promote innovation and the translation
of scientific discoveries into clinical practice.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=150
Injectable Drug Delivery Market Dynamics:
Drivers:
- Increased Prevalence of Chronic Diseases
Restraints:
- Infections associated with needlestick injuries
Opportunities:
- Increase in demand for biosimilars and generic medicine
Challenge:
- Preference for other modes of drug delivery
Key Market Players of Injectable Drug Delivery
Industry:
The prominent companies are Becton, Dickinson and Company
(U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd.
(Israel), Eli Lilly and Company
(U.S.), Baxter International, Inc. (U.S.), Sandoz (Germany), Terumo (Japan), Schott
AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland), Bespak (U.K.), and B. Braun
Melsungen (Germany).
Breakdown of supply-side primary interviews, by company type,
designation, and region:
- By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3
(35%)
- By Designation: C-level (30%), Director-level (20%), and Others
(50%)
- By Region: North America
(35%), Europe (24%), Asia Pacific (25%), RoW (16%)
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=150
Recent Developments of Injectable Drug Delivery
Industry:
- In Sep 2022 BD launched BD
EffivaxTM Glass prefillable syringes. This syringe will help in
growing demand for vaccines manufacturing.
- In Oct 2022 GSK received its
product approval for BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria
Toxoid and Acellular Pertussis Vaccine, Adsorbed; Tdap) for
immunization during the third trimester of pregnancy to help
prevent pertussis (whooping cough) in infants younger than two
months old.)
- In Nov 2023 Eli and Lilly
received FDA approval for Zepbound injection which is the first and
only obesity medication.
Injectable Drug Delivery Market - Key Benefits of Buying the
Report:
This report studies the Injectable drug delivery market based on
type, formulation packaging, site of administration, route of
administration, facility of use, distribution channels and region.
The report also analyses factors (such as drivers, restraints,
opportunities and challenges) affecting market growth. It evaluates
the opportunities and challenges in the market for stakeholders and
provides details of the competitive landscape for market leaders.
The report also studies micro markets concerning their growth
trends, prospects, and contributions to the total apheresis market.
The report forecasts the revenue of the market segments to five
major regions.
Reasons to Buy the Report
This report also includes.
- Analysis of key drivers (increasing chronic diseases,
increasing biologics, technological advancements) ,restraints
(Infections associated with needle stick injuries),
challenges(Other methods of Injectable drug delivery available in
the market), opportunities (Increase in the demand of generic
medicines and biosimilars) contributing the growth of the
Injectable drug delivery market.
- Product Development/Innovation: Detailed insights on upcoming
trends, research & development activities, in the Injectable
drug delivery market.
- Market Development: Comprehensive information on the lucrative
emerging markets by type, formulation packaging, by site of
administration,facility of use and region.
- Market Diversification: Exhaustive information about the
growing geographies, recent developments, investments in the
Injectable drug delivery market.
- Competitive Assessment: In-depth assessment of market shares,
growth strategies, product offerings, company evaluation quadrant,
and capabilities of leading players in the global Injectable drug
delivery market.
Related Reports:
Pen Needles Market - Global Forecasts to 2028
Topical Drug Delivery Market - Global Forecasts to
2027
Pharmaceutical Drug Delivery Market - Global Forecasts to
2026
Injection Pen Market - Global Forecasts to 2026
Needle-Free Injection System Market - Global Forecasts to
2026
Get access to the latest updates on Injectable Drug Delivery
Companies and Injectable Drug Delivery Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish
Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/injectable-drug-delivery-market-worth-1139-4-billion--marketsandmarkets-302136568.html